🔎 Trials Near Me

Dachaigh › Galaran Autoimmune › Illinois › Chicago

Sgrùdaidhean clionaigeach Galaran Autoimmune ann an Chicago, IL

Tha 12 sgrùdaidhean airson Galaran Autoimmune a’ lorg phàirtichean aig làraichean ann agus timcheall air Chicago (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

A’ fastadhÌre 2
  • University of Chicago, Chicago
Aoisean 16 gu 70 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07328581

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

A’ fastadhÌre 2/3
  • Ann & Robert H. Lurie Children's Hospital of Chicago - Accepting Young Adult and Juvenile Patients, Chicago
  • Northwestern Memorial Hospital - Accepting Adult Patients, Chicago
  • The University of Chicago Medical Center - Accepting Adult and Juvenile Patients, Chicago
Aoisean 6 gu 75 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT06154252

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

A’ fastadhÌre 2
  • University of Chicago, Department of Medicine: Rheumatology, Chicago
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07103746

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

A’ fastadhÌre 1
  • The University of Chicago Medical Center, Chicago
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT07085104

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

A’ fastadhÌre 1/2
  • Northwestern Memorial Hospital, Chicago
  • The University of Chicago Medical Center, Chicago
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT06121297

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

A’ fastadhÌre 1/2
  • University of Illinois Hospital & Health Sciences System, Chicago
Aoisean 35 gu 70 · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT06575426

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

A’ fastadhÌre 2/3
  • Northwestern Memorial Hospital, Chicago
  • The University of Chicago Medical Center, Chicago
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT06328777

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

A’ fastadhÌre 1/2
  • Northwestern Memorial Hospital, Chicago
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 13 Lùna 2026 · NCT06359041

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

A’ fastadhSgrùdadh amharc
  • Northwestern Memorial Hospital, Chicago
  • Rush University Medical Center, Chicago
  • University of Illinois at Chicago, Chicago
  • agus 2 a bharrachd
Gach aois · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT01351545

Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

A’ fastadhÌre 1
  • Northwestern University, Chicago
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 30 Ògmh 2026 · NCT06201416

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • University of Chicago Medical Center, Chicago
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Màrt 2026 · NCT01280825

Sgrùdaidhean Galaran Autoimmune ann am bailtean eile

Sgrùdaidhean eile ann an Chicago

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.